Clinical Trial Update: Perifosine in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perifosine in patients with advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED